Subscribe to this collection to receive daily e-mail notification of new additions

Issue Date	Title	Author(s)
2010	Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural Link	Mahesh, R.
2009	TAFI: A Potential Target for Fibrinolytic Drugs	Mahesh, R.
2010-02	Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?	Mahesh, R.
2013	An unusual case of xylophagia (paper-eating)	Mahesh, R.
2013	Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in Mice	Mahesh, R.
2013	Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential	Mahesh, R.
2015-05	Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system	Mahesh, R.
2015-01	Piperazine Analogs of Naphthyridine-3-carboxamides and Indole-2-carboxamides: Novel 5-HT3 Receptor Antagonists with Antidepressant-Like Activity	Mahesh, R.
2015	Insignificant in vitro falcipain-2 inhibitory activity of novel 2-(4-(substituted benzoyl) piperazine-1-yl)-N-phenylacetamide derivatives	Mahesh, R.
2016-01	4i (N-(3-Chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist alleviates depressive behavior evoked in streptozotocin-induced diabetic mice: Role of oxidative stress	Mahesh, R.
2010	Demographic study on disease prevalence and their treatment pattern in a local hospital of a semi-urban community	Mahesh, R.
2015-10	Pyridine-based, microwave-assisted one-pot synthetic protocol for the synthesis of ethyl 3-substituted-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates	Mahesh, R.
2015-02	Ameliorative Effect of Wortmannin and Rapamycin Treatment on Obesity Markers in High Fat Diet Feed Rats	Mahesh, R.
2017-10	Antidepressant Therapy for Depression: An Update	Mahesh, R.
2013-07	Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) in experimental mouse models of anxiety	Mahesh, R.
2013	Effect of a novel 5-HT3 receptor antagonist carboxamide, 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on the acute and chronic rodent models of depression	Mahesh, R.
2015	Insignificant in vitro falcipain‑2 inhibitory activity of novel 2‑(4‑(substituted benzoyl) piperazine‑1‑yl)‑N‑phenylacetamide derivatives	Mahesh, R.
2016-06	Antidepressant- and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine -3-carboxylic acid (7e)- An approach using rodent behavioral antidepressant and anxiolytic test battery	Mahesh, R.
2012	Evaluation of anti‑diabetic activity of methanolic extract from the bark of Atalantia monophylla (Linn.) in alloxan‑induced diabetic mice	Mahesh, R.
2013-03	Anti-depressant - Like Effect of Novel 5-HT Receptor Antagonist, (4- 3 benzylpiperazin-1-yl) (3-methoxyquinoxalin-2-yl)methanone (6g) in Acute and Chronic Animal Models of Depression	Mahesh, R.